Cargando…
CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration
Clinical evidence and experimental studies have shown the psychotomimetic properties induced by ketamine. Moreover, acute or chronic ketamine (KET) administration has been widely used for modeling schizophrenia-like symptomatology and pathophysiology. Several studies have reported the antipsychotic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578683/ https://www.ncbi.nlm.nih.gov/pubmed/34776964 http://dx.doi.org/10.3389/fphar.2021.746935 |
_version_ | 1784596283417165824 |
---|---|
author | Poulia, Nafsika Delis, Foteini Brakatselos, Charalampos Ntoulas, George Asprogerakas, Michail-Zois Antoniou, Katerina |
author_facet | Poulia, Nafsika Delis, Foteini Brakatselos, Charalampos Ntoulas, George Asprogerakas, Michail-Zois Antoniou, Katerina |
author_sort | Poulia, Nafsika |
collection | PubMed |
description | Clinical evidence and experimental studies have shown the psychotomimetic properties induced by ketamine. Moreover, acute or chronic ketamine (KET) administration has been widely used for modeling schizophrenia-like symptomatology and pathophysiology. Several studies have reported the antipsychotic potential of cannabidiol (CBD), while there is limited information on the cannabidiol effect on KET-induced schizophrenia-like impairments. Therefore, the goal of the present study was to evaluate neuroplastic changes induced by repeated KET administration, which is used as an experimental model of schizophrenia—with a behavioral focus on positive-like symptomatology– and to assess the modulatory role of CBD treatment. The present findings have shown a robust increase in motor activity in KET-treated rats, following a 10-day period of chronic administration at the sub-anesthetic dose of 30 mg/kg (i.p), that was reversed to normal by subsequent chronic CBD treatment. Concerning the expression of glutamate receptors, the current findings have shown region-dependent KET-induced constitutional alterations in NMDA and AMPA receptors that were modified by subsequent CBD treatment. Additionally, repeated KET administration increased ERK1/2 phosphorylation state in all regions examined, apart from the ventral hippocampus that was modulated by subsequent CBD treatment. The present results show, for the first time, a stimulated motor output coupled with a specific glutamatergic-related status and ERK1/2 activation following chronic KET administration that were attenuated by CBD treatment, in a region-dependent manner. These findings provide novel information concerning the antipsychotic potential of CBD using a specific design of chronic KET administration, thus contributing to experimental approaches that mirror the symptomatology and pathophysiology of schizophrenia. |
format | Online Article Text |
id | pubmed-8578683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85786832021-11-11 CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration Poulia, Nafsika Delis, Foteini Brakatselos, Charalampos Ntoulas, George Asprogerakas, Michail-Zois Antoniou, Katerina Front Pharmacol Pharmacology Clinical evidence and experimental studies have shown the psychotomimetic properties induced by ketamine. Moreover, acute or chronic ketamine (KET) administration has been widely used for modeling schizophrenia-like symptomatology and pathophysiology. Several studies have reported the antipsychotic potential of cannabidiol (CBD), while there is limited information on the cannabidiol effect on KET-induced schizophrenia-like impairments. Therefore, the goal of the present study was to evaluate neuroplastic changes induced by repeated KET administration, which is used as an experimental model of schizophrenia—with a behavioral focus on positive-like symptomatology– and to assess the modulatory role of CBD treatment. The present findings have shown a robust increase in motor activity in KET-treated rats, following a 10-day period of chronic administration at the sub-anesthetic dose of 30 mg/kg (i.p), that was reversed to normal by subsequent chronic CBD treatment. Concerning the expression of glutamate receptors, the current findings have shown region-dependent KET-induced constitutional alterations in NMDA and AMPA receptors that were modified by subsequent CBD treatment. Additionally, repeated KET administration increased ERK1/2 phosphorylation state in all regions examined, apart from the ventral hippocampus that was modulated by subsequent CBD treatment. The present results show, for the first time, a stimulated motor output coupled with a specific glutamatergic-related status and ERK1/2 activation following chronic KET administration that were attenuated by CBD treatment, in a region-dependent manner. These findings provide novel information concerning the antipsychotic potential of CBD using a specific design of chronic KET administration, thus contributing to experimental approaches that mirror the symptomatology and pathophysiology of schizophrenia. Frontiers Media S.A. 2021-10-27 /pmc/articles/PMC8578683/ /pubmed/34776964 http://dx.doi.org/10.3389/fphar.2021.746935 Text en Copyright © 2021 Poulia, Delis, Brakatselos, Ntoulas, Asprogerakas and Antoniou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Poulia, Nafsika Delis, Foteini Brakatselos, Charalampos Ntoulas, George Asprogerakas, Michail-Zois Antoniou, Katerina CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration |
title | CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration |
title_full | CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration |
title_fullStr | CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration |
title_full_unstemmed | CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration |
title_short | CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration |
title_sort | cbd effects on motor profile and neurobiological indices related to glutamatergic function induced by repeated ketamine pre-administration |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578683/ https://www.ncbi.nlm.nih.gov/pubmed/34776964 http://dx.doi.org/10.3389/fphar.2021.746935 |
work_keys_str_mv | AT poulianafsika cbdeffectsonmotorprofileandneurobiologicalindicesrelatedtoglutamatergicfunctioninducedbyrepeatedketaminepreadministration AT delisfoteini cbdeffectsonmotorprofileandneurobiologicalindicesrelatedtoglutamatergicfunctioninducedbyrepeatedketaminepreadministration AT brakatseloscharalampos cbdeffectsonmotorprofileandneurobiologicalindicesrelatedtoglutamatergicfunctioninducedbyrepeatedketaminepreadministration AT ntoulasgeorge cbdeffectsonmotorprofileandneurobiologicalindicesrelatedtoglutamatergicfunctioninducedbyrepeatedketaminepreadministration AT asprogerakasmichailzois cbdeffectsonmotorprofileandneurobiologicalindicesrelatedtoglutamatergicfunctioninducedbyrepeatedketaminepreadministration AT antonioukaterina cbdeffectsonmotorprofileandneurobiologicalindicesrelatedtoglutamatergicfunctioninducedbyrepeatedketaminepreadministration |